Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

Published:2024-03 Issue:10429 Volume:403 Page:850-859
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rech Juergen,Tascilar Koray,Hagen Melanie,Kleyer Arnd,Manger Bernhard,Schoenau Verena,Hueber Axel J,Kleinert Stefan,Baraliakos Xenofon,Braun Jürgen,Kiltz Uta,Fleck Martin,Rubbert-Roth Andrea,Kofler David M,Behrens Frank,Feuchtenberger Martin,Zaenker Michael,Voll Reinhard,Venhoff Nils,Thiel Jens,Glaser Cornelia,Feist Eugen,Burmester Gerd R,Karberg Kirsten,Strunk Johannes,Cañete Juan D,Senolt Ladislav,Filkova Maria,Naredo Esperanza,Largo Raquel,Krönke Gerhard,D'Agostino Maria-Antonietta,Østergaard Mikkel,Schett Georg

Funder

Deutsche Forschungsgemeinschaft

Bundesministerium für Bildung und Forschung

European Commission

European Research Council

Publisher

Elsevier BV

Reference37 articles.

1. The pathogenesis of rheumatoid arthritis;McInnes;N Engl J Med,2011

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update;Smolen;Ann Rheum Dis,2023

3. Pathogenetic insights from the treatment of rheumatoid arthritis;McInnes;Lancet,2017

4. Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis;Catrina;Nat Rev Rheumatol,2017

5. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis;Rantapää-Dahlqvist;Arthritis Rheum,2003

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Environment and systemic autoimmune rheumatic diseases: an overview and future directions;Frontiers in Immunology;2024-09-10

2. Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease;Annals of the Rheumatic Diseases;2024-09-06

3. Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence;Autoimmunity Reviews;2024-09

4. A predictive model for progression to clinical arthritis in at-risk individuals with arthralgia based on lymphocyte subsets and ACPA;Rheumatology;2024-08-09

5. Prevention of Rheumatoid Arthritis in At-Risk Individuals: Current Status and Future Prospects;Drugs;2024-07-02